Айна Парк - В постели с бактериями. История, наука и секреты микроскопических существ, о которых не принято говорить

5. Grant R. M., Lama J. R., Anderson P. L., McMahan V., Liu A. Y., Vargas L., Goicochea P., Casapia M., Guanira-Carranza J. V., Ramirez-Cardich M. E., Montoya-Herrera O., Fernández T., Veloso V. G., Buchbinder S. P., Chariyalertsak S., Schechter M., Bekker L. G., Mayer K. H., Kallás E. G., Amico K. R., Mulligan K., Bushman L. R., Hance R. J., Ganoza C., Defechereux P., Postle B., Wang F., McConnell J. J., Zheng J. H., Lee J., Rooney J. F., Jaffe H. S., Martinez A. I., Burns D. N., Glidden D. V.; iPrEx Study Team. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010 Dec 30;363(27):2587–99.

6. Baeten J. M., Donnell D., Ndase P., Mugo N. R., Campbell J. D., Wangisi J., Tappero J. W., Bukusi E. A., Cohen C. R., Katabira E., Ronald A., Tumwesigye E., Were E., Fife K. H., Kiarie J., Farquhar C., John-Stewart G., Kakia A., Odoyo J., Mucunguzi A., Nakku-Joloba E., Twesigye R., Ngure K., Apaka C., Tamooh H., Gabona F., Mujugira A., Panteleeff D., Thomas K. K., Kidoguchi L., Krows M., Revall J., Morrison S., Haugen H., Emmanuel-Ogier M., Ondrejcek L., Coombs R. W., Frenkel L., Hendrix C., Bumpus N. N., Bangsberg D., Haberer J. E., Stevens W. S., Lingappa J. R., Celum C.; Partners PrEP Study Team. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012 Aug 2;367(5):399–410.

7. Duran D. Truvada whores? Huffington Post. November 12, 2012. Updated February 2, 2016. Accessed September 10, 2017. Available at: https://www.huffpost.com/entry/truvada-whoresb2113588.

8. U.S. Public Health Service. Preexposure prophylaxis for the prevention of HIV infection the United States—2014. Available at: https://www.cdc.gov/hiv/pdf/prepguidelines2014.pdf. Accessed September 1, 2017.

9. Smith D. K., Van Handel M., Wolitski R. J., Stryker J. E., Hall H. I., Prejean J., Koenig L. J., Valleroy L. A.. Vital signs: estimated percentages and numbers of adults with indications for preexposure prophylaxis to prevent HIV acquisition – United States, 2015. MMWR Morb Mortal Wkly Rep. 2015 Nov 27;64(46):1291–5.

10. AIDS Healthcare Foundation. PrEP: the revolution that didn’t happen. Available at: https://www.aidshealth.org/#/archives/24286. Accessed June 8, 2017.

11. Centers for Disease Control and Prevention. HIV among gay and bisexual men. https://www.cdc.gov/hiv/group/msm/index.html. Accessed March 7, 2020.

12. Marrazzo J. M., Ramjee G., Richardson B. A., Gomez K., Mgodi N., Nair G., Palanee T., Nakabiito C., van der Straten A., Noguchi L., Hendrix C. W., Dai J. Y., Ganesh S., Mkhize B., Taljaard M., Parikh U. M., Piper J., Mâsse B., Grossman C., Rooney J., Schwartz J. L.,Watts H., Marzinke M. A., Hillier S. L., McGowan I. M., Chirenje Z. M.; VOICE Study Team. Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2015 Feb 5;372(6):509–18.

13. van der Straten A., Stadler J., Montgomery E., Hartmann M., Magazi B., Mathebula F., Schwartz K… Laborde N., Soto-Torres L. Women’s Experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa. PLOS ONE. 2014 Feb 21;9(2):e89118.

14. van der Straten A., Montgomery E.T., Musara P., Etima J., Naidoo S., Laborde N., Hartmann M., Levy L., Bennie T., Cheng H., Piper J., Grossman C.I., Marrazzo J., Mensch B.; Microbicide Trials Network-003D Study Team. Disclosure of pharmacokinetic drug results to understand nonadherence. AIDS. 2015 Oct 23;29(16):2161–71.

15. Centers for Disease Control and Prevention. HIV risk and prevention estimates. Available at: https://www.cdc.gov/hiv/risk/estimates/riskbehaviors.html. Accessed August 30, 2017.

16. Cohen M. S., Chen Y. Q., McCauley M., Gamble T., Hosseinipour M. C., Kumarasamy N., Hakim J. G., Kumwenda J., Grinsztejn B., Pilotto J. H., Godbole S. V., Mehendale S., Chariyalertsak S., Santos B. R., Mayer K. H., Hoffman I. F., Eshleman S. H., Piwowar-Manning E., Wang L., Makhema J., Mills L. A., de Bruyn G., Sanne I., Eron J., Gallant J., Havlir D., Swindells S., Ribaudo H., Elharrar V., Burns D., Taha T. E., Nielsen-Saines K., Celentano D., Essex M., Fleming T. R.; HPTN 052 Study Team. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011 Aug 11;365(6):493–505.

17. Cohen M. S., Chen Y. Q., McCauley M., Gamble T., Hosseinipour M. C., Kumarasamy N., Hakim J. G., Kumwenda J., Grinsztejn B., Pilotto J. H., Godbole S. V., Chariyalertsak S., Santos B. R., Mayer K. H., Hoffman I. F., Eshleman S. H., Piwowar-Manning E., Cottle L., Zhang X. C., Makhema J., Mills L. A., Panchia R., Faesen S., Eron J., Gallant J., Havlir D., Swindells S., Elharrar V., Burns D., Taha T. E., Nielsen-Saines K., Celentano D. D., Essex M., Hudelson S. E., Redd A. D., Fleming T. R.; HPTN 052 Study Team. Antiretroviral therapy for the prevention of hiv-1 transmission. N Engl J Med. 2016 Sep 1;375(9):830–9.

18. Bavinton B. R., Pinto A. N., Phanuphak N., Grinsztejn B., Prestage G. P., Zablotska-Manos I. B., Jin F., Fairley C. K., Moore R., Roth N., Bloch M., Pell C., McNulty A. M., Baker D., Hoy J., Tee B. K., Templeton D. J., Cooper D. A., Emery S., Kelleher A., Grulich A. E.; Opposites Attract Study Group. Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study. Lancet HIV. 2018 Aug;5(8):e438–47.

19. Rodger A. J., Cambiano V., Bruun T., Vernazza P., Collins S., van Lunzen J., Corbelli G. M., Estrada V., Geretti A. M., Beloukas A., Asboe D., Viciana P., Gutiérrez F., Clotet B., Pradier C., Gerstoft J., Weber R., Westling K., Wandeler G., Prins J. M., Rieger A., Stoeckle M., Kümmerle T., Bini T., Ammassari A., Gilson R., Krznaric I., Ristola M., Zangerle R., Handberg P., Antela A., Allan S., Phillips A. N., Lundgren J.; PARTNER Study Group. Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the hiv-positive partner is using suppressive antiretroviral therapy. JAMA. 2016 Jul 12;316(2):171–81. doi: 10.1001/jama.2016.5148. Erratum in: JAMA. 2016 Aug 9;316(6):667. JAMA. 2016 Nov 15;316(19):2048.

20. Rodger A. J., Cambiano V., Bruun T., Vernazza P., Collins S., Degen O., Corbelli G. M., Estrada V., Geretti A. M., Beloukas A., Raben D., Coll P., Antinori A., Nwokolo N., Rieger A., Prins J. M., Blaxhult A., Weber R., Van Eeden A., Brockmeyer N. H., Clarke A., Del Romero Guerrero J., Raffi F., Bogner J. R., Wandeler G., Gerstoft J., Gutiérrez F., Brinkman K., Kitchen M., Ostergaard L., Leon A., Ristola M., Jessen H., Stellbrink H. J., Phillips A. N., Lundgren J.; PARTNER Study Group. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet. 2019 Jun 15;393(10189):2428–38.

21. Finlayson T., Cha S., Xia M., et al. Changes in HIV Preexposure prophylaxis awareness and use among men who have sex with men—20 urban areas, 2014 and 2017. MMWR Morb Mortal Wkly Rep. 2019;68:597–603.

1. Farrington E. M., Bell D. C., DiBacco A. E. Reasons people give for using (or not using) condoms. AIDS Behav. 2016 Dec;20(12):2850–62.

2. Daniels K., Abma J. C. Current contraceptive status among women aged 15–49: United States, 2015–2017. Available at: https://www.cdc.gov/nchs/data/databriefs/db327-h.pdf. Accessed May 22, 2019.

3. Kann L., McManus T., Harris W. A., et al. Youth Risk Behavior Surveillance – United States, 2017. MMWR Surveill Summ. 2018;67(No. SS-8):1–114.

4. United Nations, Department of Economic and Social Affairs, Population Division (2015). Trends in Contraceptive Use Worldwide 2015 (ST/ESA/SER.A/349).